Our results demonstrate that melatonin consumption for 14 days significantly decreases plasma levels of IL-4, IL-2, IL-1β, IFN-γ, and IL-6 (Esmaeili Gouvarchin Ghaleh et al., 2021; Hosseini et al., 2021) in COVID-19 patients. Here, IL2 is linked to COVID-19.